Özge Demircan Tulacı

Özge Demircan Tulacı

Auto-generated profile, based on publicly available information

Özge Demircan Tulacı

Faculty of Medicine, Department of Child and Adolescent Psychiatry Balıkesir University Balıkesir Türkiye

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2022 in Journal of Nervous & Mental Disease
Verified
Journal Article
Closed access
RTRıza Gökçer Tulacı
Rıza Gökçer Tulacı
ÖTÖzge Demircan Tulacı
Özge Demircan Tulacı
NDNazan Dolapoğlu
Nazan Dolapoğlu
We aimed to investigate the effect of the COVID-19 pandemic on the symptom severity and dimensions of obsessive-compulsive disorder (OCD) and how patients with different levels of insight have been impacted by the pandemic. This study included 58 patients with OCD. The Yale-Brown Obsessive Compulsive Scale (Y-BOCS)–Obsession, Y-BOCS–Compulsion, and Y-BOCS–Total scores during the pandemic were significantly higher than the prepandemic scores (p = 0.001, p < 0.001, p = 0.002, respectively). Compared with the pre-COVID-19 period, severity of OCD symptoms increased in 39.7% patients, remained the same in 44.8% patients, and reduced in 15.5% patients during the pandemic. The obsession with contamination, Brown Assessment of Beliefs Scale (for insight assessment) score, and time spent following the news/data about COVID-19 were significantly associated with an increase in OCD severity. In patients with contamination obsessions as well as poor insight, close monitoring and facilitating access to treatment may reduce the negative impact of the COVID-19 pandemic.

30 December 2021 in Düzce Tıp Fakültesi Dergisi
Verified
Journal Article
Open access
PDF file
AEAyşe Nihal ERASLAN
Ayşe Nihal ERASLAN
IDİbRahim Durukan
İbRahim Durukan
ŞBŞahin Bodur
Şahin Bodur
ÖDÖzge Demi̇rCan
Özge Demi̇rCan
Aim: Autism spectrum disorder is a neurodevelopmental disorder. The S100 calcium binding protein B (S100B) is among the markers of astrocyte activation as well as brain damage. Herein, it was aimed to evaluate S100B levels to determine whether there is a relation with the severity of autism spectrum disorder and establish possible causes of different results among the studies in the literature from a psychiatric and biochemical perspective. Material and Methods: Twenty-five male children with autism spectrum disorder were included as the study group along with twenty-seven male children as the control group. The childhood autism rating scale and the autism behavior checklist were applied. Serum S100B protein levels were measured by enzyme-linked immunosorbent assay (ELISA). Results: The mean serum S100B level was 1008.61±171.34 pg/mL in the study group and 1060.14±182.83 pg/mL in the control group, and no statistically significant difference was found between the groups (p=0.300). Based on the childhood autism rating scale scores, 60% (n=15) of the children with autism spectrum disorder had severe autism, whereas 40% (n=10) had mild-to-moderate autism. There was no significant difference in terms of the serum S100B levels between the groups of autism spectrum disorder severity (p=0.935) or according to the autistic regression status (p=0.667). Conclusion: For S100B to be accepted as a reliable biomarker for autism spectrum disorder, more studies considering some factors with larger samples should be performed. Moreover, to understand the effect of biochemical methodology on the results, further studies are suggested on this subject.

7 July 2022 in Turkish Journal of Pediatric Disease
Verified
Journal Article
Open access
PDF file
GAGülhan Atakul
Gülhan Atakul
KAKazım Aslan
Kazım Aslan
ÖDÖzge Demi̇rcan
Özge Demi̇rcan
PÖPerihan Özhan
Perihan Özhan
AÇAtika Çağlar
Atika Çağlar
Objective: The role of social workers, who are beginning to be integrated into the entire health system, is now becoming more and more understood. In our study, we aimed to discuss the duties of social workers at PICU, the results of their work in harmony with the physicians, and their importance for the intensive care team. Material and Methods: Sixtysix children aged between 1 month and 18 years old who were asked for social service consultation between January 2019 and December 2020 at our hospital’s PICU were included in the study. The age, diagnosis, sex, marital status (married-divorced), number of days of hospitalization, number of recurrent hospitalization, reason and result of consultation, necessity of psychiatric consultation and frequency of follow-up were retrospectively examined and recorded through the hospital information system. The collected data were analyzed by means of SPSS (version 22.0, SPSS Inc. Chicago, IL, USA). Results: The median age (months) (min-max) was found to be 172, 50 (6-209), and the median (min-max) duration of hospitalization (days) was found to be 2 (1-76). Family neglect was found to be the most common cause of social work indications (77.3%; n: 51). The number of patients who were given social counseling and referred to a psychiatrist was 25 (37.9%). Family neglect and abuse were detected in 5 (7.6%) patients. Apart from these, it was observed that problems such as drug supply, financial support, ID application, home device supply assistance, care center approvals and child custody were solved in each 1 (1.5%) patient. Conclusion: The inclusion of social workers in the children’s intensive care unit teams can also prevent many social problems that can be neglected otherwise. Physicians are more focused on patient treatment, so we believe that it will be beneficial to question the family and social status of patients together with a social service unit and specialists integrated into children’s intensive care units.

14 March 2026 in Epilepsy & Behavior
Verified
Journal Article
Closed access
ÖAÖzlem Kemer Aycan
Özlem Kemer Aycan
HAHilal Aydin
Hilal Aydin
ÖTÖzge Demircan Tulacı
Özge Demircan Tulacı

30 April 2018 in Psychiatry and Clinical Psychopharmacology
Verified
Journal Article
Open access
VÇVeysi Çeri
Veysi Çeri
HAHasan Cem Aykutlu
Hasan Cem Aykutlu
IGIşık Görker
Işık Görker
ÖAÖmer Faruk Akça
Ömer Faruk Akça
MTMahmut Cem Tarakçıoğlu
Mahmut Cem Tarakçıoğlu
VGVahdet Görmez
Vahdet Görmez
(2018). Symposium Oral Presentations. Psychiatry and Clinical Psychopharmacology: Vol. 28, 10th International Congress on Psychopharmacology & 6th International Symposium on Child and Adolescent Psychopharmacology 2018 Abstracts, pp. 297-391.

30 June 2022 in Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi
Verified
Journal Article
Closed access
HBHILMI BOLAT
HILMI BOLAT
HCHamıde Betul GERİK CELEBİ
Hamıde Betul GERİK CELEBİ
GÜGül Ünsel-Bolat
Gül Ünsel-Bolat
EGEsra Çolak Geni̇ş
Esra Çolak Geni̇ş
ÖDÖzge Demi̇rcan
Özge Demi̇rcan
SÇSırrı Çam
Sırrı Çam
Giriş ve Amaç: Gelişim geriliği (GG) ve entelektüel yetersizlik (EY) fenotipik ve genetik olarak heterojen bir grup hastalıktır. GG/EY olguların etiyolojisinde altta yatan önemli bir kısmını genetik nedenler oluşturmaktadır. Bu araştırmadaki amacımız, GG/EY tanısı olan olguların genetik tanılama oranlarına ilişkin verilerin araştırılmasıydı. Gereç ve Yöntemler: GG/EY ön tanısıyla Ocak 2020 ile Aralık 2020 tarihleri arasında gelişim testlerine yönlendirilen 0-6 yaş arasında 578 olgunun hastane kayıtları retrospektif incelendi. Bu olgulara yönelik yapılan genetik testlerin sonuçları değerlendirmeye alındı. Bulgular: Yapılan gelişim testi sonucunda GG/EY saptanan olguların oranı %68,3 idi. GG/EY tanısı alan olguların içerisinde genetik polikliniğine başvuruda bulunan olguların oranı ise %7,4 idi. Uygulanan genetik testler sonucunda GG/EY ile ilişkili genetik varyant saptanma oranı %37,9 idi. Sonuç: Nörogelişimsel bozukluklarda genetik değerlendirme ve genetik testlere ulaşıma ilişkin kısıtlılıklar tüm dünyada önemli bir sorun olarak karşımıza çıkmaktadır. Çalışmamızda GG/EY olgularının genetiğe yönlendirme oranı ulaşılabilir birçok ülke verileri ile kıyaslandığında düşük olarak saptanmıştır. Ülkemizde GG/EY tanılı olgular için uygun genetik danışmanlığı sağlamak, prognozu belirleyebilmek ve gelecek nesillere yönelik birincil koruma sağlayabilmek için ülke genelinde uygulanabilecek sağlık politikalarına ihtiyaç duyulmaktadır.